Furthermore, compared to the BC group, the mRNA expression levels of AQP4 did not significantly decrease in the CS group, compared to the CS group, but was enhanced in the CS + FSD group (p < 0.05) (Fig. 7). The gene discussed is AQP4; the disease is breast cancer.